Corona Remedies is an India-focused branded pharmaceutical formulation company engaged in developing, manufacturing and marketing products in women’s healthcare, cardio-diabeto, pain management, urology and other therapeutic areas. Its diversified product portfolio comprises brands that cater to a range of therapeutic areas such as women’s healthcare, cardio-diabeto, pain management, urology and others/multispecialty pharmaceuticals (comprising vitamins/minerals/nutrition (VMN), gastrointestinal and respiratory.

CORONA Remedies major competitors are Abbott India, Alkem Laboratories, Eris Lifesciences, Glaxosmithkline Phar, JB Chem & Pharma, Mankind Pharma, Pfizer.
Market Cap of CORONA Remedies is ₹8,912 Crs.
While the median market cap of its peers are ₹30,059 Crs.

CORONA Remedies seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.